Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line
Related Experiment Video
Updated: Aug 19, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Eriko Fujimoto1, Hiromi Sato, Sumiko Shirai
1Department of Food Science Research for Health, National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku, 162-8636 Tokyo, Japan.
Abstract:
Connexin genes expressing gap junction proteins have tumor-suppressive effects on primary cancers with certain cell specificity, but the suppressive effects on metastatic cancers are still conflicting. In this study, we show that connexin32 (Cx32) has a strong tumor-suppressive effect on a human metastatic renal cell carcinoma cell line (Caki-1 cell). Cx32 expression in Caki-1 cells reduced in vitro malignant phenotypes of the cells such as anchorage independency and invasion capacity. Furthermore, the Cx32 expression drastically reduced the development of Caki-1 cells in nude mice. We also determined that Cx32 reduced the malignant phenotypes in Caki-1 cells mainly through the inactivation of Src signaling. Especially, Cx32-dependent inactivation of Src decreased the production of vascular epithelial growth factor (VEGF) via the suppression of signal transducers and activators of transcription 3 (Stat3) activation, and we confirmed this result using short interfering RNA. In nude mice, Cx32-transfected Caki-1 cells showed lower serum level of VEGF comparing mock transfectant, and the development of the cells in nude mice positively related to the VEGF level. These data suggest that Cx32 acts as a tumor suppressor gene in Caki-1 cells and that the tumor-suppressive effect partly depends on the inhibition of Src-Stat3-VEGF signal pathway.
Insights
Connexin 32 (Cx32) suppresses metastasis in renal cell carcinoma by inhibiting the Src-Stat3-VEGF pathway. This study demonstrates Cx32
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Connexin genes, encoding gap junction proteins, exhibit tumor-suppressive roles in primary cancers.
- The impact of connexins on metastatic cancers remains debated, necessitating further investigation.
Purpose of the Study:
- To investigate the tumor-suppressive potential of connexin 32 (Cx32) in a human metastatic renal cell carcinoma cell line (Caki-1).
- To elucidate the molecular mechanisms underlying Cx32's effects on Caki-1 cell malignancy and metastasis.
Main Methods:
- Cx32 expression was introduced into Caki-1 cells.
- In vitro assays assessed anchorage independence and invasion capacity.
- In vivo studies evaluated tumor development in nude mice.
- Western blotting and short interfering RNA (siRNA) were used to analyze signaling pathways, including Src, Stat3, and vascular endothelial growth factor (VEGF).
Main Results:
- Cx32 expression significantly reduced in vitro malignant phenotypes of Caki-1 cells.
- Cx32 expression markedly inhibited Caki-1 cell tumor development in nude mice.
- Cx32 exerted its tumor-suppressive effects primarily by inactivating Src signaling.
- This inactivation led to decreased VEGF production via suppression of signal transducers and activators of transcription 3 (Stat3) activation.
- Cx32-transfected cells showed lower serum VEGF levels in vivo, correlating with reduced tumor growth.
Conclusions:
- Connexin 32 (Cx32) functions as a tumor suppressor gene in metastatic renal cell carcinoma (Caki-1 cells).
- The tumor-suppressive activity of Cx32 is partly mediated by the inhibition of the Src-Stat3-VEGF signaling pathway.
- Targeting the Cx32-mediated pathway may offer therapeutic strategies for metastatic renal cell carcinoma.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Replicative Cell Senescence
Abnormal Proliferation